Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
BMY News
If you’re holding Bristol-Myers Squibb or eyeing it as a potential buy, you’re not alone in wondering what move makes sense right now. The stock has tested even...
Tim Anderson, an analyst from Bank of America Securities, reiterated the Hold rating on Bristol-Myers Squibb. The associated price target remains the same with...
Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our P/B Growth Invest...
Analyst ratings
69%
of 29 ratingsMore BMY News
Earlier this month, Bristol-Myers Squibb announced that the US FDA granted Fast Track designation to its experimental Alzheimer's treatment BMS-986446, currentl...
Princeton, New Jersey-based Bristol-Myers Squibb Company ( BMY ) is one of the leading biopharmaceutical companies focused on developing treatments for diseases...
Bristol-Myers Squibb (BMY) shares have seen steady declines over the past month, with the stock ending yesterday at $43.96. Investors are taking a closer look a...
Below is Validea's guru fundamental report for BRISTOL-MYERS SQUIBB CO (BMY). Of the 22 guru strategies we follow, BMY rates highest using our Low PE Investor m...
Bristol Myers Squibb (BMY) stock was down on Friday after the biopharmaceutical company announced its acquisition of private biotechnology company Orbital Thera...